New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
09:23 EDTZMH, NUVA, COV, SYK, STJ, BSX, IART, EWBarclays medical supplies/devices analysts hold analyst/industry conference call
Medical Supplies & Devices Analysts provide a review of the recently held Barclay's Medtech Symposium on an Analyst/Industry conference call. Relevant companies COV, BSX, STJ, MDT, EW, NUVA, IART, SYK and ZMH may be discussed on the Analyst/Industry conference call to be held on April 15 at 10:30 am.
News For BSX;COV;EW;STJ;NUVA;IART;SYK;ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
13:34 EDTSYKStryker shares look inexpensive, should continue to rise, Barron's says
Despite rising more than 30% over the past year, shares of Stryker still have plenty of upside potential, Barron's reports. The company sports industry-leading organic sales, a strong balance sheet, and is trading at a discount to the broader medical device industry, all of which should push shares higher, Barron's adds. Reference Link
07:38 EDTBSXBoston Scientific risk/reward favorable after trial ends, says Wells Fargo
Subscribe for More Information
December 15, 2014
07:32 EDTNUVAStifel to hold a bus tour
Subscribe for More Information
December 12, 2014
09:02 EDTBSXBoston Scientific presents data of Precision Spinal Cord Stimulator system
Subscribe for More Information
December 11, 2014
05:23 EDTSTJSt. Jude Medical announces CE Mark approval of Quadra Allure MP CRT-P
Subscribe for More Information
December 10, 2014
07:38 EDTBSXBoston Scientific management to meet with Deutsche Bank
Subscribe for More Information
06:01 EDTBSXBoston Scientific implied volatility of 38 at upper end of index mean range
December 9, 2014
10:27 EDTBSXOptions with increasing implied volatility
Subscribe for More Information
08:07 EDTEWEdwards Lifesciences price target raised to $155 from $135 at JMP Securities
Subscribe for More Information
07:36 EDTEWEdwards Lifesciences TAVI growth reinforces bullish stance, says Canaccord
Subscribe for More Information
07:29 EDTIARTIntegra LifeSciences shares undervalued, says Oppenheimer
Subscribe for More Information
07:07 EDTEWEdwards price target raised to $151-$152 from $135-$140 at Wells Fargo
Wells Fargo increased its price target on Edwards Lifesciences as the firm believes that the company's roughly in-line 2015 guidance announced yesterday is conservative.The firm also notes that the company raised its long-term TAVR market assumption to over $3B in 2019. The firm keeps an Outperform rating on the shares.
December 8, 2014
12:42 EDTSYKStryker resolves government investigation of OtisMed matter
Subscribe for More Information
10:42 EDTBSXOptions with increasing implied volatility
Subscribe for More Information
08:16 EDTEWEdwards Lifesciences announces investments in CardioKinetix
Edwards made a structured investment in CardioKinetix, a privately held medical device company pioneering a catheter-based treatment for heart failure. This transaction increases Edwards' existing minority interest in CardioKinetix and provides an option to purchase the remaining outstanding shares for a future payment, plus additional milestone payments based on future regulatory and reimbursement approvals. In the second investment, the company acquired intellectual property that broadens its transcatheter mitral valve development efforts. Additional details of both investments were not disclosed.
08:15 EDTEWEdwards Lifesciences sees FY15 EPS $3.90-$4.10, consensus $3.96
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences backs FY14 EPS $3.33-$3.39, consensus $3.39
Subscribe for More Information
06:05 EDTEWEdwards Lifesciences to host investor meeting
Subscribe for More Information
05:53 EDTBSXStocks with implied volatility movement; BSX BMY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use